Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 6

Results: 44

Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 894, doi. 10.1038/sj.leu.2403690

By:

Korkolopoulou, P.;
Thymara, I.;
Kavantzas, N.;
Vassilakopoulos, T. P.;
Angelopoulou, M. K.;
Kokoris, S. I.;
Dimitriadou, E. M.;
Siakantaris, M. P.;
Anargyrou, K.;
Panayiotidis, P.;
Tsenga, A.;
Androulaki, A.;
Doussis-Anagnostopoulou, I. A.;
Patsouris, E.;
Pangalis, G. A.

Publication type:

Article

Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript.

Published in:

2005

By:

Meyer-Monard, S;
Mühlematter, D;
Streit, A;
Chase, A J;
Gratwohl, A;
Cross, N C P;
Jotterand, M;
Tichelli, A

Publication type:

Letter

Five decades of therapy for multiple myeloma: a paradigm for therapeutic models.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 910, doi. 10.1038/sj.leu.2403728

By:

Kyle, R. A.

Publication type:

Article

New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.

Published in:

2005

By:

Kohlmann, A.;
Schoch, C.;
Dugas, M.;
Schnittger, S.;
Hiddemann, W.;
Kern, W.;
Haferlach, T.

Publication type:

journal article

G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.

Published in:

2005

By:

Ausserlechner, M. J.;
Obexer, P.;
Geley, S.;
Kofler, R.

Publication type:

journal article

Can application of serine protease inhibitors TPCK and TLCK provide evidence for possible involvement of serine protease Omi/HtrA2 in imatinib mesylate-induced cell death of BCR-ABL-positive human leukemia cells?

Published in:

2005

By:

Mlejnek, P

Publication type:

Letter

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 971, doi. 10.1038/sj.leu.2403721

By:

Yoshimi, A.;
Bader, P.;
Matthes-Martin, S.;
Starý, J.;
Sedlacek, P.;
Duffner, U.;
Klingebiel, T.;
Dilloo, D.;
Holter, W.;
Zintl, F.;
Kremens, B.;
Sykora, K.-W.;
Urban, C.;
Hasle, H.;
Korthof, E.;
R.évész, T.;
Fischer, A.;
Nöllke, P.;
Locatelli, F.;
Niemeyer, C. M.

Publication type:

Article

The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1005, doi. 10.1038/sj.leu.2403712

By:

Walz, C.;
Chase, A.;
Schoch, C.;
Weisser, A.;
Schlegel, F.;
Hochhaus, A.;
Fuchs, R.;
Schmitt-Gräff, A.;
Hehlmann, R.;
Cross, N. C. P.;
Reiter, A.

Publication type:

Article

Nonproliferating CML CD34<sup>+</sup> progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1034, doi. 10.1038/sj.leu.2403724

By:

Holtz, M. S.;
Forman, S. J.;
Bhatia, R.

Publication type:

Article

CLL family‘Pedigree 14’revisited: 1947-2004.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1025, doi. 10.1038/sj.leu.2403727

By:

Jønsson, V.;
Houlston, R. S.;
Catovsky, D.;
Yuille, M. R.;
Hilden, J.;
Olsen, J. H.;
Fajber, M.;
Brandt, B.;
Sellick, G.;
Allinson, R.;
Wiik, A.

Publication type:

Article

Untreated essential thrombocythemia evolving to biphenotypic leukemia, Philadelphia chromosome positive with monosomy 7: response to imatinib and reduced-intensity allogeneic stem cell transplant.

Published in:

2005

By:

Martin, S E;
DellaValla, J

Publication type:

Letter

ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1018, doi. 10.1038/sj.leu.2403726

By:

Nolz, J. C.;
Tschumper, R. C.;
Pittner, B. T.;
Darce, J. R.;
Kay, N. E.;
Jelinek, D. F.

Publication type:

Article

Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.

Published in:

2005

By:

Kerbauy, F. R.;
Storb, R.;
Hegenbart, U.;
Gooley, T.;
Shizuru, J.;
Al-Ali, H. K.;
Radich, J. P.;
Maloney, D. G.;
Agura, E.;
Bruno, B.;
Epner, E. M.;
Chauncey, T. R.;
Blume, K. G.;
Niederwieser, D.;
Sandmaier, B. M.

Publication type:

journal article

t(11;14) does not predict long-term survival in myeloma.

Published in:

2005

By:

Chang, H.;
Qi, X. Y.;
Stewart, A. K.

Publication type:

Letter

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 916, doi. 10.1038/sj.leu.2403770

By:

Mohty, M.;
de Lavallade, H.;
Ladaique, P.;
Faucher, C.;
Vey, N.;
Coso, D.;
Stoppa, A.-M.;
Gastaut, J.-A.;
Blaise, D.

Publication type:

Article

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 945, doi. 10.1038/sj.leu.2403733

By:

van Imhoff, G. W.;
van der Holt, B.;
MacKenzie, M. A.;
Ossenkoppele, G. J.;
Wijermans, P. W.;
Kramer, M. H. H.;
van't Veer, M. B.;
Schouten, H. C.;
van Marwijk Kooy, M.;
van Oers, M. H. J.;
Raemaekers, J. M. M.;
Sonneveld, P.;
Meulendijks, L. A. M. H.;
Kluin, P. M.;
Kluin-Nelemans, H. C.;
Verdonck, L. F.

Publication type:

Article

Genetic heterogeneity of the hypervariable region I of Hepatitis C virus and lymphoproliferative disorders.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1070, doi. 10.1038/sj.leu.2403731

By:

Rigolet, A.;
Cacoub, P.;
Schnuriger, A.;
Vallat, L.;
Cahour, A.;
Ghillani, P.;
Davi, F.;
Benhamou, Y.;
Piette, J.-C.;
Thibault, V.

Publication type:

Article

Identification of genes potentially involved in disease transformation of CML.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 998, doi. 10.1038/sj.leu.2403735

By:

Janssen, J. J. W. M.;
Klaver, S. M.;
Waisfisz, Q.;
Pasterkamp, G.;
de Kleijn, D. P. V.;
Schuurhuis, G. J.;
Ossenkoppele, G. J.

Publication type:

Article

Identification of Ki23819, a highly potent inhibitor of kinase activity of mutant FLT3 receptor tyrosine kinase.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 930, doi. 10.1038/sj.leu.2403736

By:

Komeno, Y.;
Kurokawa, M.;
Imai, Y.;
Takeshita, M.;
Matsumura, T.;
Kubo, K.;
Yoshino, T.;
Nishiyama, U.;
Kuwaki, T.;
Osawa, T.;
Ogawa, S.;
Chiba, S.;
Miwa, A.;
Hirai, H.

Publication type:

Article

Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy.

Published in:

2005

By:

Mejstríková, E.;
Kalina, T.;
Trka, J.;
Starý, J.;
Hrušák, O.

Publication type:

Letter

Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.

Published in:

2005

By:

Guo, Y.;
Karube, K.;
Kawano, R.;
Yamaguchi, T.;
Suzumiya, J.;
Huang, G.-S.;
Ohshima, K.

Publication type:

journal article

Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.

Published in:

2005

By:

Chow, K. U.;
Nowak, D.;
Hofmann, W.;
Schneider, B.;
Hofmann, W.-K.

Publication type:

Letter

Reply to‘Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4’by Chow et al.

Published in:

2005

By:

Aloyz, R;
Panasci, L

Publication type:

Letter

Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1042, doi. 10.1038/sj.leu.2403749

By:

Andersson, A.;
Edén, P.;
Lindgren, D.;
Nilsson, J.;
Lassen, C.;
Heldrup, J.;
Fontes, M.;
Borg, Å.;
Mitelman, F.;
Johansson, B.;
Höglund, M.;
Fioretos, T.

Publication type:

Article

Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays.

Published in:

2005

By:

Mestre, C.;
Rubio-Moscardo, F.;
Rosenwald, A.;
Climent, J.;
Dyer, M. J. S.;
Staudt, L.;
Pinkel, D.;
Siebert, R.;
Martinez-Climent, J. A.

Publication type:

Letter

Reply to Aloyz et al.

Published in:

2005

By:

Chow, K. U.;
Nowak, D.;
Hofmann, W.;
Schneider, B.;
Hofmann, W.-K.

Publication type:

Letter

Identification of an HLA-A1 restricted CTL epitope from Mcl-1.

Published in:

2005

By:

Andersen, M. H.;
Kvistborg, P.;
Becker, J. C.;
thor Straten, P.

Publication type:

Letter

Apoptosis-resistant phenotype of classical Hodgkin's lymphoma is not mediated by somatic mutations within genes encoding members of the death-inducing signaling complex (DISC).

Published in:

2005

By:

Thomas, R. K.;
Schmitz, R.;
Harttrampf, A. C.;
Abdil-Hadi, A.;
Wickenhauser, C.;
Distler, V.;
Hansmann, M.-L.;
Schultze, J. L.;
Küppers, R.;
Wolf, J.

Publication type:

Letter

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1029, doi. 10.1038/sj.leu.2403745

By:

Dreger, P.;
Brand, R.;
Milligan, D.;
Corradini, P.;
Finke, J.;
Lambertenghi Deliliers, G.;
Martino, R.;
Russell, N.;
van Biezen, A.;
Michallet, M.;
Niederwieser, D.

Publication type:

Article

Therapeutic research in untreated acute promyelocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 913, doi. 10.1038/sj.leu.2403767

By:

Estey, E.

Publication type:

Article

STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.

Published in:

2005

By:

Holtick, U.;
Vockerodt, M.;
Pinkert, D.;
Schoof, N.;
Stürzenhofecker, B.;
Kussebi, N.;
Lauber, K.;
Wesselborg, S.;
Löffler, D.;
Horn, F.;
Trümper, L.;
Kube, D.;
Stürzenhofecker, B;
Löffler, D;
Trümper, L

Publication type:

journal article

Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1064, doi. 10.1038/sj.leu.2403751

By:

Sharkey, R. M.;
Karacay, H.;
Chang, C.-H.;
McBride, W. J.;
Horak, I. D.;
Goldenberg, D. M.

Publication type:

Article

Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes.

Published in:

2005

By:

Hernández, J. M.;
Castilla, C.;
Gutiérrez, N. C.;
Isidro, I. M.;
Delgado, M.;
de las Rivas, J.;
Fermiñán, E.;
García, J. L.;
Ocio, E. M.;
del Cañizo, M. C.;
San Miguel, J. F.

Publication type:

Letter

Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 901, doi. 10.1038/sj.leu.2403754

By:

Sanda, T.;
Kuwano, T.;
Nakao, S.;
Iida, S.;
Ishida, T.;
Komatsu, H.;
Shudo, K.;
Kuwano, M.;
Ono, M.;
Ueda, R.

Publication type:

Article

CBFß-SMMHC slows proliferation of primary murine and human myeloid progenitors.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 921, doi. 10.1038/sj.leu.2403755

By:

D'Costa, J.;
Chaudhuri, S.;
Civin, C. I.;
Friedman, A. D.

Publication type:

Article

Gender aspects in chronic myeloid leukemia: long-term results from randomized studies.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 984, doi. 10.1038/sj.leu.2403756

By:

Berger, U.;
Maywald, O.;
Pfirrmann, M.;
Lahaye, T.;
Hochhaus, A.;
Reiter, A.;
Hasford, J.;
Heimpel, H.;
Hossfeld, D. K.;
Kolb, H.-J.;
Löffler, H.;
Pralle, H.;
Queisser, W.;
Hehlmann, R.

Publication type:

Article

Thrombocytopenia after gemtuzumab is reversible by intravenous immunoglobulin.

Published in:

2005

By:

Leung, A. Y. H.;
Liang, R.

Publication type:

Case Study

High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation.

Published in:

2005

By:

Shimazaki, C.;
Uchida, R.;
Nakano, S.;
Namura, K.;
Fuchida, S.-I.;
Okano, A.;
Okamoto, M.;
Inaba, T.

Publication type:

Letter

Dichotomy of all-trans retinoic acid inducing signals for adult T-cell leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 1010, doi. 10.1038/sj.leu.2403760

By:

Yamaguchi, T.;
Maeda, Y.;
Ueda, S.;
Hijikata, Y.;
Morita, Y.;
Miyatake, J.-I;
Matsuda, M.;
Kanamaru, A.

Publication type:

Article

Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 965, doi. 10.1038/sj.leu.2403763

By:

Alonzo, T. A.;
Wells, R. J.;
Woods, W. G.;
Lange, B.;
Gerbing, R. B.;
Buxton, A. B.;
Neudorf, S.;
Sanders, J.;
Smith, F. O.;
Feig, S. A.

Publication type:

Article

High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 978, doi. 10.1038/sj.leu.2403766

By:

Schlenk, R. F.;
Germing, U.;
Hartmann, F.;
Glasmacher, A.;
Fischer, J. T.;
del Valle y Fuentes, F.;
Götze, K.;
Pralle, H.;
Nerl, C.;
Salwender, H.;
Grimminger, W.;
Petzer, A.;
Hensel, M.;
Benner, A.;
Zick, L.;
Döhner, K.;
Fröhling, S.;
Döhner, H.

Publication type:

Article

Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: new answers for an old question.

Published in:

Leukemia (08876924), 2005, v. 19, n. 6, p. 891, doi. 10.1038/sj.leu.2403771

By:

Shimoni, A.;
Nagler, A.

Publication type:

Article

CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients.

Published in:

2005

By:

Minuzzo, S;
Indraccolo, S;
Tosello, V;
Piovan, E;
Cabrelle, A;
Trentin, L;
Semenzato, G;
Amadori, A

Publication type:

Letter

Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines.

Published in:

2005

By:

Ding, Y.;
Li, Z.;
Broome, J. D.

Publication type:

Correction Notice